review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Barbara J Marston | |
Ahmed Saadani Hassani | |||
P2860 | cites work | Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique | Q21034056 |
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review | Q21133667 | ||
Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach | Q26859055 | ||
Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review | Q28084544 | ||
Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi | Q28387497 | ||
Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness | Q28732179 | ||
Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review | Q33288230 | ||
Cost of community integrated prevention campaign for malaria, HIV, and diarrhea in rural Kenya | Q34107939 | ||
Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda | Q34359439 | ||
Interactions between malaria and human immunodeficiency virus anno 2014 | Q34404275 | ||
Advancement of global health: key messages from the Disease Control Priorities Project | Q34514169 | ||
The impact of HIV care and support interventions on key outcomes in low- and middle-income countries: a literature review--introduction | Q35576963 | ||
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana | Q36094775 | ||
HIV and malaria: interactions and implications | Q36696361 | ||
Reducing the burden of malaria in pregnancy by preventive strategies | Q36717628 | ||
Use of insecticide treated net and malaria preventive education: effect on malaria parasitemia among people living with AIDS in Nigeria, a cross-sectional study | Q37114810 | ||
Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease | Q37339874 | ||
The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women | Q37398249 | ||
Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda | Q37429678 | ||
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea | Q38868223 | ||
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort | Q38872771 | ||
Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. | Q38879071 | ||
Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda | Q38879309 | ||
Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study | Q38879589 | ||
Effect of iron supplementation and malaria prophylaxis in infants on Plasmodium falciparum genotypes and multiplicity of infection | Q38898985 | ||
Mortality and morbidity from malaria after stopping malaria chemoprophylaxis | Q39113594 | ||
Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. | Q39489364 | ||
Clinical burden and correlates of HIV and malaria co-infection, in northwest Nigeria | Q40138849 | ||
Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial | Q42249162 | ||
Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study | Q42263673 | ||
Evaluation of impact of long-lasting insecticide-treated bed nets and point-of-use water filters on HIV-1 disease progression in Kenya | Q43353878 | ||
Multiclonal asymptomatic Plasmodium falciparum infections predict a reduced risk of malaria disease in a Tanzanian population | Q43633050 | ||
Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group | Q43836224 | ||
Cotrimoxazole prophylaxis and malaria in Africa: Have the important questions been answered? | Q45066715 | ||
Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials | Q47844653 | ||
Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? | Q47877517 | ||
Malaria and HIV infection in subSaharan Africa: another match made in hell? | Q48001031 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
insecticide | Q181322 | ||
prevention of HIV/AIDS | Q7242372 | ||
malaria prevention | Q93598033 | ||
P304 | page(s) | S306-17 | |
P577 | publication date | 2015-04-01 | |
P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
P1476 | title | Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review | |
P478 | volume | 68 Suppl 3 |